What's Trending

Your source for perspectives, case studies and resources on the trends shaping oncology and cardiology benefit management

  • Video: Cancer Care Costs Everyone Too Much. What Can Health Plans Do About It?

    Video: Cancer Care Costs Everyone Too Much. What Can Health Plans Do About It?

    New Century Health’s John Davis hosts a virtual “fireside chat” with Dr. Elizabeth Malko, Dr. Vinay Prasad, and Dr. Andrew Hertler.

    Watch Video
  • Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors

    Evolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors

    Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.

    Read Article
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    Pathways, Portals and Persuasion: Reining in an Overused Cancer Agent

    NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.

    Read Article
  • Experts and Execs Weigh In: Oncology Care in 2021 and Beyond

    Experts and Execs Weigh In: Oncology Care in 2021 and Beyond

    New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.

    Read Article
  • Let's Go
  • New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services

    New Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services

    The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.

    Read Article
  • Key Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad

    Key Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad

    New Century Health's John Davis recently sat down with Dr. Prasad, author of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer," to discuss key forces impacting cancer care.

    Watch Video
  • Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Oncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping

    Read External Article
  • How Real-World Evidence Can Transform High-Value Oncology Pathways

    How Real-World Evidence Can Transform High-Value Oncology Pathways

    Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.

    Read Article
  • High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    High-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend

    Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.

    Read Article
  • New Century Health Achieves NCQA Accreditation in Utilization Management

    New Century Health Achieves NCQA Accreditation in Utilization Management

    NCH also recertified by HITRUST® for patient privacy and data security protection.

    Read Press Release
  • Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois

    Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois

    Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.

    Read Article
  • How Clinical Pathways Are Growing

    How Clinical Pathways Are Growing

    Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.

    Read External Article
  • Clinical Pathways Slow Drug Spending in Community Oncology

    Clinical Pathways Slow Drug Spending in Community Oncology

    Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers

    Read External Article
  • A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    A Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology

    Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.

    Watch Video
  • Let's Go
  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Illinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend

    Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols

    Read Press Release
  • On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care

    Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.

    Watch Webinar
  • New Century Health Pathways Help Community Practice Reduce Drug Spending

    New Century Health Pathways Help Community Practice Reduce Drug Spending

    Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.

    Read External Article
  • The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    The Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable

    Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.

    Watch Video
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • COVID-19 Resources for Providers and Health Plans

    COVID-19 Resources for Providers and Health Plans

    A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.

    Read Article
  • loading
    Loading More...